![United States: FDA Approves Sandoz Denosumab Biosimilars - Goodwin Procter LLP](https://cdn.newsserve.net/ONPglobe256.png)
United States: FDA Approves Sandoz Denosumab Biosimilars - Goodwin Procter LLP
On March 5, Sandoz announced that the FDA approved its denosumab biosimilars, WYOST and JUBBONTI, as interchangeable with Amgen's XGEVA and PROLIA.
Full Article
On March 5, Sandoz announced that the FDA approved its denosumab biosimilars, WYOST and JUBBONTI, as interchangeable with Amgen's XGEVA and PROLIA.
Full ArticleOn March 7, Fresenius Kabi announced that the FDA has approved its tocilizumab biosimilar, TYENNE (tocilizumab-aazg) for..